The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Cited by (1,513)

Items 701–800 of 1,513

1. In vivo quantification of neurofibrillary tangles with [18F]MK-6240
   Tharick Ali Pascoal, Monica Shin, Min Su Kang, Mira Chamoun, Daniel A. Chartrand, Sulantha Sanjeewa Mathotaarachchi, Idriss Bennacef, Joseph Therriault, Kok Pin Ng, Robert Hopewell et al. · 2018 · Alzheimer s Research & Therapy
2. An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
   Nicholas James Ashton, Abdul Hye, Anto Praveen Rajkumar, Antoine Leuzy, Stuart G. Snowden, Marc Suárez‐Calvet, Thomas K. Karikari, Michael Schöll, Renaud La Joie, Gil Dan Rabinovici et al. · 2020 · Nature Reviews Neurology
3. Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
   Prestia, Annapaola, Caroli, Anna, van der Flier, Wiesje M., Ossenkoppele, Rik, Van Berckel, Bart, Barkhof, Frederik, Teunissen, Charlotte E., Wall, Anders E., Carter, Stephen F., Schöll, Michael et al. · 2013 · Neurology
4. Plasma microRNA biomarkers for detection of mild cognitive impairment
   Sheinerman, Kira S., Tsivinsky, Vladimir G., Crawford, Fiona, Mullan, Michael J., Abdullah, Laila, Umansky, Samuil R. · 2012 · Aging
5. Structural neuroimaging as clinical predictor: A review of machine learning applications
   José María Mateos-Pérez, Mahsa Dadar, María Lacalle-Aurioles, Yasser Iturria‐Medina, Yashar Zeighami, Alan C. Evans · 2018 · NeuroImage Clinical
6. Gait variability across neurodegenerative and cognitive disorders: Results from the Canadian Consortium of Neurodegeneration in Aging (CCNA) and the Gait and Brain Study
   Frederico Pieruccini‐Faria, Sandra E. Black, Mario Masellis, Eric Edward Smith, Quincy J. Almeida, Karen Li, Louis Bherer, Richard M. Camicioli, Manuel Montero‐Odasso · 2021 · Alzheimer s & Dementia
7. The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
   Öhrfelt, Annika, Brinkmalm, Ann, Dumurgier, Julien, Brinkmalm, Gunnar, Hansson, Oskar, Zetterberg, Henrik, Bouaziz-Amar, Elodie, Hugon, Jacques, Paquet, Claire, Blennow, Kaj · 2016 · Alzheimer's Research & Therapy
8. A Longitudinal Follow-Up of 550 Mild Cognitive Impairment Patients: Evidence for Large Conversion to Dementia Rates and Detection of Major Risk Factors Involved
   Ana Espinosa, Montserrat Alegret, Sergi Valero, Georgina Vinyes‐Junque, Isabel Hernández, Ana Mauleón, Maitée Rosende‐Roca, Agustı́n Ruiz, Oscar L. López, Lluís Tárraga et al. · 2013 · Journal of Alzheimer s Disease
9. MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data
   Jun‐ichi Satoh, Yoshihiro Kino, Shumpei Niida · 2015 · Biomarker Insights
10. Effects of 6-month at-home transcranial direct current stimulation on cognition and cerebral glucose metabolism in Alzheimer's disease
    Jooyeon Jamie Im, Hyeonseok S. Jeong, Marom Bikson, Adam J. Woods, Gozde Unal, Jin Kyoung Oh, Seunghee Na, Jong‐Sik Park, Helena Knotková, In‐Uk Song et al. · 2019 · Brain stimulation
11. Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
    Avinash Chandra, Polytimi‐Eleni Valkimadi, Gennaro Pagano, Oliver Cousins, George Dervenoulas, Marios Politis, Alzheimer’s Disease Neuroimaging Initiative · 2019 · Human Brain Mapping
12. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline
    Joanne L. Ryan, Elsdon Storey, Anne M. Murray, Robyn L. Woods, Rory S Wolfe, Christopher Michael Reid, Mark Raymond Nelson, Trevor T.‐J. Chong, Jeff D. Williamson, Stephanie Alison Ward et al. · 2020 · Neurology
13. Functional network connectivity in the behavioral variant of frontotemporal dementia
    Filippi, Massimo, Agosta, Federica, Scola, Elisa, Canu, Elisa, Magnani, Giuseppe, Marcone, Alessandra, Valsasina, Paola, Caso, Francesca, Copetti, Massimiliano, Comi, Giancarlo et al. · 2013 · Cortex
14. Automated Cognitive Health Assessment Using Smart Home Monitoring of Complex Tasks
    Prafulla Dawadi, Diane J. Cook, Maureen Schmitter‐Edgecombe · 2013 · IEEE Transactions on Systems Man and Cybernetics Systems
15. Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia
    Howard A Fink, Eric Jutkowitz, John Riley McCarten, Laura S. Hemmy, Mary Butler, Heather Wood Davila, Edward R. Ratner, Collin Calvert, Terry R. Barclay, Michelle Brasure et al. · 2017 · Annals of Internal Medicine
16. How can dementia and disability be prevented in older adults: where are we today and where are we going?
    Inna Lisko, Jenni Kulmala, Martin Annetorp, Tiia Ngandu, Francesca Mangialasche, Miia Kivipelto · 2020 · Journal of Internal Medicine
17. Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
    Cicognola, Claudia, Brinkmalm, Gunnar, Wahlgren, Jessica, Portelius, Erik, Gobom, Johan, Cullen, Nicholas C., Hansson, Oskar, Parnetti, Lucilla, Constantinescu, Radu, Wildsmith, Kristin et al. · 2019 · Acta Neuropathologica
18. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls
    Bellenguez, Céline, Charbonnier, Camille, Grenier-Boley, Benjamin, Quenez, Olivier, Le Guennec, Kilan, Nicolas, Gaël, Chauhan, Ganesh, Wallon, David, Rousseau, Stéphane, Richard, Anne Claire et al. · 2017 · Neurobiology of Aging
19. Human Brain Networks in Cognitive Decline: A Graph Theoretical Analysis of Cortical Connectivity from EEG Data
    Vecchio, Fabrizio, Miraglia, Francesca, Marra, Camillo, Quaranta, Davide, Vita, Maria Gabriella, Bramanti, Placido, Rossini, Paolo Maria · 2014 · Journal of Alzheimer's Disease
20. CSF biomarkers cutoffs: The importance of coincident neuropathological diseases
    Toledo, Jon B., Brettschneider, Johannes, Grossman, Murray, Arnold, Steven E., Hu, William T., Xie, Sharon X., Lee, Virginia M.-Y., Shaw, Leslie M., Trojanowski, John Q. · 2012 · Acta Neuropathologica
21. Gradual Disturbances of the Amplitude of Low-Frequency Fluctuations (ALFF) and Fractional ALFF in Alzheimer Spectrum
    Yang, Liu, Yan, Yan, Wang, Yonghao, Hu, Xiaochen, Lu, Jie, Chan, Piu, Yan, Tianyi, Han, Ying · 2018 · Frontiers in Neuroscience
22. Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment
    Jiri M.G. Van Bergen, Xu Li, Jun Hua, Simon J. Schreiner, Stephanie C. Steininger, Frances C. Quevenco, Matthias Tasso Wyss, Anton Franz Gietl, Valérie Treyer, Sandra E. Leh et al. · 2016 · Scientific Reports
23. AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies
    Kejal Kantarci, Val J. Lowe, Bradley F. Boeve, Matthew L. Senjem, Nirubol Tosakulwong, Timothy G. Lesnick, Anthony J. Spychalla, Jeffrey L. Gunter, Julie A. Fields, Jonathan Graff‐Radford et al. · 2016 · Annals of Neurology
24. Epigenetics of Alzheimer’s Disease
    Matea Nikolac Perković, Alja Videtič Paska, Marcela Konjevod, Katarina Kouter, Dubravka Švob Štrac, Gordana Nedić Erjavec, Nela Pivac · 2021 · Biomolecules
25. Associations Between Biomarkers and Age in the Presenilin 1 E280A Autosomal Dominant Alzheimer Disease Kindred: A Cross-sectional Study
    Fleisher, Adam S., Chen, Kewei, Quiroz, Yakeel T., Jakimovich, Laura J., Gutierrez Gomez, Madelyn, Langois, Carolyn M., Langbaum, Jessica B. S., Roontiva, Auttawut, Thiyyagura, Pradeep, Lee, Wendy et al. · 2015 · JAMA Neurology
26. Cholinesterase inhibitors for mild cognitive impairment
    Tom C. Russ, Joanne R Morling · 2012 · Cochrane Database of Systematic Reviews
27. Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors
    Steven H. Ferris, Martin Rhys Farlow · 2013 · Clinical Interventions in Aging
28. Sleep Quality and Aging: A Systematic Review on Healthy Older People, Mild Cognitive Impairment and Alzheimer’s Disease
    Maria Casagrande, Giuseppe Forte, Francesca Favieri, Ilaria Corbo · 2022 · International Journal of Environmental Research and Public Health
29. Everyday impact of cognitive interventions in mild cognitive impairment: a systematic review and meta-analysis
    Chandler, M. J., Parks, A. C., Marsiske, M., Rotblatt, L. J., Smith, G. E. · 2016 · Neuropsychology Review
30. Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play
    Jack, Clifford R. · 2012 · Radiology
31. Plasma tau/amyloid-β1–42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer’s disease
    Jong‐Chan Park, Sun-Ho Han, Dahyun Yi, Min Soo Byun, Jun Ho Lee, Sukjin S. Jang, Kang Ko, So Yeon Jeon, Yun‐Sang Lee, Yu Kyeong Kim et al. · 2018 · Brain
32. Epidemiology of aging and associated cognitive disorders: Prevalence and incidence of Alzheimer's disease and other dementias
    Oscar L. López, Lewis H. Kuller · 2019 · Handbook of clinical neurology
33. Cognitive Impairment in Older Adults
    Nicolás Pérez Palmer, Barbara Trejo Ortega, Pallavi Joshi · 2022 · Psychiatric Clinics of North America
34. Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease
    Lawrence S. Honig, Marwan Noel Sabbagh, Christopher H. van Dyck, Reisa Anne Sperling, Steven M. Hersch, André P. C. Matta, Luigi Giorgi, Michelle Gee, Michio Kanekiyo, David Li et al. · 2024 · Alzheimer s Research & Therapy
35. Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias
    Baiardi, Simone, Quadalti, Corinne, Mammana, Angela, Dellavalle, Sofia, Zenesini, Corrado, Sambati, Luisa, Pantieri, Roberta, Polischi, Barbara, Romano, Luciano, Suffritti, Matteo et al. · 2022 · Alzheimer's Research & Therapy
36. Type 2 diabetes as a risk factor for cognitive impairment: current insights
    Hiroyuki Umegaki · 2014 · Clinical Interventions in Aging
37. Visual and Ocular Manifestations of Alzheimer’s Disease and Their Use as Biomarkers for Diagnosis and Progression
    Fatimah Zara Javaid, Jonathan Brenton, Li Guo, Maria Francesca Cordeiro · 2016 · Frontiers in Neurology
38. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry
    Sørensen, Lauge, Igel, Christian, Pai, Akshay, Balas, Ioana, Anker, Cecilie, Lillholm, Martin, Nielsen, Mads · 2017 · NeuroImage: Clinical
39. Neural oscillations and brain stimulation in Alzheimer’s disease
    Zahra Jafari, Bryan E Kolb, Majid H. Mohajerani · 2020 · Progress in Neurobiology
40. Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated
    John L. Robinson, Sharon Xiangwen Xie, Daniel R. Baer, EunRan R. Suh, Vivianna M. Van Deerlin, Nicholas Loh, David John Irwin, Corey T. McMillan, David A. Wolk, Alice S. Chen‐Plotkin et al. · 2023 · Brain
41. Speech Analysis by Natural Language Processing Techniques: A Possible Tool for Very Early Detection of Cognitive Decline?
    Beltrami, Daniela, Gagliardi, Gloria, Rossini Favretti, Rema, Ghidoni, Enrico, Tamburini, Fabio, Calzà, Laura · 2018 · Frontiers in Aging Neuroscience
42. Omega-3 fatty acids for the treatment of dementia
    Marion Burckhardt, Max Herke, Tobias Wustmann, Stefan Watzke, Gero Langer, Astrid Maria Fink · 2016 · Cochrane Database of Systematic Reviews
43. Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease
    Katherine R. Gray, Robin Wolz, Rolf A. Heckemann, Paul Aljabar, Alexander Hammers, Daniel Rueckert · 2012 · NeuroImage
44. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation
    Lorenzo Gaetani, Kina Höglund, Lucilla Parnetti, Fani Pujol-Calderón, Bruno Becker, Paolo Eusebi, Paola Sarchielli, Paolo Calabresi, Massimiliano Di Filippo, Henrik Zetterberg et al. · 2018 · Alzheimer s Research & Therapy
45. Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
    T. Betthauser, R. Koscik, E. Jonaitis, S. Allison, K. Cody, Claire M. Erickson, H. Rowley, C. Stone, K. Mueller, Lindsay R. Clark et al. · 2019 · Brain : a journal of neurology
46. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic <i>APP</i> mutation carriers
    Schöll, Michael, Wall, Anders, Thordardottir, Steinunn, Ferreira, Daniel, Bogdanovic, Nenad, Långström, Bengt, Almkvist, Ove, Graff, Caroline, Nordberg, Agneta · 2012 · Neurology
47. Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease
    Brookmeyer, Ron, Abdalla, Nada · 2018 · Alzheimer's &amp; Dementia
48. Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study
    AV45-A11 Study Group, Doraiswamy, P M, Sperling, R A, Johnson, K, Reiman, E M, Wong, T Z, Sabbagh, M N, Sadowsky, C H, Fleisher, A S, Carpenter, A et al. · 2014 · Molecular Psychiatry
49. Right anterior temporal lobe dysfunction underlies theory of mind impairments in semantic dementia
    Muireann Irish, John R. Hodges, Olivier Piguet · 2014 · Brain
50. Revised Criteria for Mild Cognitive Impairment May Compromise the Diagnosis of Alzheimer Disease Dementia
    John C. Morris · 2012 · Archives of Neurology
51. Mild Cognitive Impairment in Moderate to Severe COPD
    Sylvia Villeneuve, Véronique Pepin, Shady Rahayel, Josie‐Anne Bertrand, Myriam de Lorimier, Amanda Rizk, Catherine Desjardins, Simon Parenteau, François Beaucage, Steve Joncas et al. · 2012 · CHEST Journal
52. Networks of tau distribution in Alzheimer’s disease
    Merle C. Hoenig, Gérard N. Bischof, Joseph Seemiller, Jochen Hammes, Juraj Kukolja, Oezguer A. Onur, Frank Jessen, Klaus Fließbach, Bernd Neumaier, Gereon R. Fink et al. · 2017 · Brain
53. Rich club disturbances of the human connectome from subjective cognitive decline to Alzheimer's disease
    Tianyi Yan, Wenhui Wang, Yang Liu, Kewei Chen, Rong Chen, Ying Han · 2018 · Theranostics
54. A molecular gradient along the longitudinal axis of the human hippocampus informs large-scale behavioral systems
    Jacob W. Vogel, Renaud La Joie, Michel J. Grothe, Alex Diaz-Papkovich, Andrew Doyle, Étienne Vachon‐Presseau, Claude Lepage, Reinder Vos de Wael, Rhalena A. Thomas, Yasser Iturria‐Medina et al. · 2020 · Nature Communications
55. Lower Brain 18 F-Fluorodeoxyglucose Uptake But Normal 11 C-Acetoacetate Metabolism in Mild Alzheimer's Disease Dementia
    Christian‐Alexandre Castellano, Scott Nugent, Nancy Paquet, Sébastien Tremblay, Christian Bocti, Guy Lacombe, Hélène Imbeault, Éric E. Turcotte, Tamàs Fülöp, Stephen C. Cunnane · 2014 · Journal of Alzheimer s Disease
56. Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
    Min Cheol Han, Eric P. Nagele, Cassandra A. DeMarshall, Nimish K. Acharya, Robert G. Nagele · 2012 · PLoS ONE
57. 11C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease
    William Charles Kreisl, Chul Hyoung Lyoo, Jeih‐San Liow, Monica H. Wei, Joseph Snow, Emily Page, Kimberly J. Jenko, Cheryl L. Morse, Sami S. Zoghbi, Victor William Pike et al. · 2016 · Neurobiology of Aging
58. 18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseases
    David N. Soleimani‐Meigooni, Leonardo Iaccarino, Renaud La Joie, Suzanne L. Baker, Viktoriya Bourakova, Adam L. Boxer, Lauren Edwards, Rana April Eser, Maria‐Luisa Gorno‐Tempini, William J. Jagust et al. · 2020 · Brain
59. SPECT and PET imaging in Alzheimer’s disease
    Valotassiou, Varvara, Malamitsi, Julia, Papatriantafyllou, John, Dardiotis, Efthimios, Tsougos, Ioannis, Psimadas, Dimitrios, Alexiou, Sotiria, Hadjigeorgiou, George, Georgoulias, Panagiotis · 2018 · Annals of Nuclear Medicine
60. Beta-amyloid imaging with florbetaben
    O. Sabri, J. Seibyl, C. Rowe, H. Barthel · 2015 · Clinical and translational imaging
61. Comorbidity and dementia: A nationwide survey in Taiwan
    Ting‐Bin Chen, Szu-Yu Yiao, Yu Sun, Huey-Jane Lee, Shu-Chien Yang, Ming‐Jang Chiu, Ta‐Fu Chen, Ker-Neng Lin, Li-Yu Tang, Chung‐Chih Lin et al. · 2017 · PLoS ONE
62. Exposure to gamma tACS in Alzheimer’s disease: A randomized, double-blind, sham-controlled, crossover, pilot study
    Alberto Benussi, Valentina Cantoni, Maria Sofia Cotelli, Maria Cotelli, Chiara Brattini, Abhishek Datta, Chris Thomas, Emiliano Santarnecchi, Álvaro Pascual‐Leone, Barbara Borroni · 2021 · Brain stimulation
63. Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia
    Ferrer, Isidro · 2012 · Progress in Neurobiology
64. Cingulum Microstructure Predicts Cognitive Control in Older Age and Mild Cognitive Impairment
    Claudia Metzler‐Baddeley, Derek Kenton Jones, Jessica J. Steventon, Laura Jayne Westacott, John P. Aggleton, Michael J O'Sullivan · 2012 · Journal of Neuroscience
65. The Risk of Incident Mild Cognitive Impairment and Progression to Dementia Considering Mild Cognitive Impairment Subtypes
    Tzeyu L. Michaud, Dejun Su, Mohammad Siahpush, Daniel L. Murman · 2017 · Dementia and Geriatric Cognitive Disorders Extra
66. White matter hyperintensity topography in Alzheimer's disease and links to cognition
    Garnier‐Crussard, Antoine, Bougacha, Salma, Wirth, Miranka, Dautricourt, Sophie, Sherif, Siya, Landeau, Brigitte, Gonneaud, Julie, De Flores, Robin, de la Sayette, Vincent, Vivien, Denis et al. · 2022 · Alzheimer's &amp; Dementia
67. Relative incidence of seizures and myoclonus in Alzheimer’s disease, dementia with lewy bodies, and frontotemporal dementia.
    Beagle, Alexander J., Darwish, Sonja M., Ranasinghe, Kamalini G., La, Alice L., Karageorgiou, Elissaios, Vossel, Keith A. · 2017 · Journal of Alzheimer's Disease
68. Association of Atrial Fibrillation With Cognitive Decline and Dementia Over 20 Years: The ARIC‐NCS (Atherosclerosis Risk in Communities Neurocognitive Study)
    Lin Y. Chen, Faye L. Norby, Rebecca F. Gottesman, Thomas H. Mosley, Elsayed Z. Soliman, Sunil K. Agarwal, Laura R. Loehr, Aaron R. Folsom, Josef Coresh, Álvaro Alonso · 2018 · Journal of the American Heart Association
69. Reproducibility of EEG functional connectivity in Alzheimer’s disease
    Casper T. Briels, Deborah N. Schoonhoven, Cornelis Jan Stam, Hanneke de Waal, Philip Scheltens, Alida A. Gouw · 2020 · Alzheimer s Research & Therapy
70. Common and unique gray matter correlates of episodic memory dysfunction in frontotemporal dementia and alzheimer's disease
    Muireann Irish, Olivier Piguet, John R. Hodges, Michael Hornberger · 2013 · Human Brain Mapping
71. Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study
    Marjolein M. A. Engels, Cornelis Jan Stam, Wiesje M. van der Flier, Philip Scheltens, Hanneke de Waal, Elisabeth C.W. van Straaten · 2015 · BMC Neurology
72. The evolution of primary progressive apraxia of speech
    Keith A. Josephs, Joseph R. Duffy, Edythe A. Strand, Mary M. Machulda, Matthew L. Senjem, Jeffrey L. Gunter, Christopher G. Schwarz, Robert I. Reid, Anthony J. Spychalla, Val J. Lowe et al. · 2014 · Brain
73. Hippocampal subfield volumes at 7T in early Alzheimer's disease and normal aging
    Laura E.M. Wisse, Geert Jan Biessels, Sophie M. Heringa, Hugo J. Kuijf, Dineke Koek, Peter R. Luijten, Mirjam I. Geerlings · 2014 · Neurobiology of Aging
74. The Differentiation of Amnestic Type MCI from the Non-Amnestic Types by Structural MRI
    Gábor Csukly, Enikő Sirály, Zsuzsanna Fodor, Andras Attila Horvath, Pál Salacz, Zoltán Hidasi, Éva Csibri, Gábor Rudas, Ádám Szabó · 2016 · Frontiers in Aging Neuroscience
75. The ARIC-PET amyloid imaging study
    Rebecca F. Gottesman, Andrea L.C. Schneider, Yun Zhou, Xueqi Chen, Edward Green, Naresh Gupta, David S. Knopman, Akiva Mintz, Arman Rahmim, A. Richey Sharrett et al. · 2016 · Neurology
76. Cognitive Training Using a Novel Memory Game on an iPad in Patients with Amnestic Mild Cognitive Impairment (aMCI)
    George Savulich, Thomas Piercy, Chris Fox, John Suckling A, James Benedict Rowe, John Tiernan O'Brien, Barbara Jacquelyn Sahakian · 2017 · The International Journal of Neuropsychopharmacology
77. Modifications and Trafficking of APP in the Pathogenesis of Alzheimer’s Disease
    Xin Wang, Xuan Zhou, Gongying Li, Yun Zhang, Yili Wu, Weihong Song · 2017 · Frontiers in Molecular Neuroscience
78. Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease
    Michael Wagner, Stefanie Wolf, Friedel Martin Reischies, Moritz Daerr, Steffen Wolfsgruber, Frank Jessen, Julius Popp, Wolfgang Maier, Michael Hüll, Lutz Frölich et al. · 2012 · Neurology
79. Age and diagnostic performance of Alzheimer disease CSF biomarkers
    Niklas Mattsson, E. Rosén, Oskar Hansson, Nancy C. Andreasen, Lucilla Parnetti, Michael A. G. Jonsson, Sanna‐Kaisa Herukka, Wiesje M. van der Flier, Marinus A. Blankenstein, Michael Ewers et al. · 2012 · Neurology
80. MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer’s Disease
    Paul M. McKeever, Raphaël Schneider, Foad Taghdiri, Anna Weichert, Namita Multani, Robert A. Brown, Adam L. Boxer, Anna Karydas, Bruce L. Miller, Janice Robertson et al. · 2018 · Molecular Neurobiology
81. Computerised cognitive training for preventing dementia in people with mild cognitive impairment
    Nicola J. Gates, Robin W.M. Vernooij, Marcello Di Nisio, Salman Karim, Evrim Gocer March, Gabriel Martínez, Anne WS Rutjes · 2019 · Cochrane Database of Systematic Reviews
82. Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells‐derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial
    Xinyi Xie, Qingxiang Song, Chengxiang Dai, Shishuang Cui, Ran Tang, Suke Li, Jing Kai Chang, Ping Li, Jin‐Tao Wang, Jianping Li et al. · 2023 · General Psychiatry
83. Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech
    H. Botha, J. Duffy, J. Whitwell, Edythe A. Strand, M. Machulda, C. Schwarz, Robert I. Reid, A. Spychalla, M. Senjem, David T. W. Jones et al. · 2015 · Cortex; a journal devoted to the study of the nervous system and behavior
84. Association of epileptiform abnormalities and seizures in Alzheimer disease.
    Lam, Alice D., Sarkis, Rani A., Pellerin, Kyle R., Jing, Jin, Dworetzky, Barbara A., Hoch, Daniel B., Jacobs, Claire S., Lee, Jong Woo, Weisholtz, Daniel S., Zepeda, Rodrigo et al. · 2020 · Neurology
85. Mild Cognitive Impairment in Geriatrics
    Eric G. Tangalos, Ronald Carl Petersen · 2018 · Clinics in Geriatric Medicine
86. Midlife vascular risk factors and risk of incident dementia: Longitudinal cohort and Mendelian randomization analyses in the UK Biobank
    Rainer Malik, Marios K. Georgakis, Julia Neitzel, Kristiina Rannikmäe, Michael Ewers, Sudha S. Seshadri, Cathie L. M. Sudlow, Martin Dichgans · 2021 · Alzheimer s & Dementia
87. Activities of Daily Living: Where do They Fit in the Diagnosis of Alzheimer’s disease?
    Gad A. Marshall, Rebecca England Amariglio, Reisa Anne Sperling, Dorene M. Rentz · 2012 · Neurodegenerative Disease Management
88. Enhanced neural activation with blueberry supplementation in mild cognitive impairment
    Erin L. Boespflug, James C. Eliassen, Jonathan A. Dudley, Marcelle D. Shidler, Wilhelmina Kalt, Suzanne S. Summer, Amanda L. Stein, Amanda Nicole Stover, Robert Krikorian · 2017 · Nutritional Neuroscience
89. Physical Activity: A Viable Way to Reduce the Risks of Mild Cognitive Impairment, Alzheimer’s Disease, and Vascular Dementia in Older Adults
    Patrick J. Gallaway, Hiroji Miyake, Maciej S. Buchowski, Mieko Shimada, Yutaka YOSHITAKE, Angela Kim, Nobuko Kay Hongu · 2017 · Brain Sciences
90. Reproducible evaluation of classification methods in Alzheimer's disease: Framework and application to MRI and PET data
    Jorge Samper‐Gonzàlez, Ninon Burgos, Simona Bottani, Sabrina Fontanella, Pascal Lu, Arnaud Marcoux, Alexandre Routier, Jérémy Guillon, Michael Bacci, Junhao Wen et al. · 2018 · NeuroImage
91. Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
    Erik Portelius, Bob Olsson, Kina Höglund, Nicholas C. Cullen, Hlin Kvartsberg, Ulf Andréasson, Henrik Zetterberg, Åsa Sandelius, Leslie M. J. Shaw, Virginia M.‐Y. Lee et al. · 2018 · Acta Neuropathologica
92. Identification of Alzheimer's disease using a convolutional neural network model based on T1-weighted magnetic resonance imaging
    Jong Bin Bae, Subin Lee, Wonmo Jung, Sejin Park, Weonjin Kim, Hyunwoo Oh, Ji Won Han, Grace Eun Kim, Jun Sung Kim, Jae Hyoung Kim et al. · 2020 · Scientific Reports
93. Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid‐life: A randomized trial
    Siobhan M. Hoscheidt, Ashley Hannah Sanderlin, Laura D. Baker, Youngkyoo Jung, Samuel Neal Lockhart, Derek Kellar, Christopher T. Whitlow, Angela J. Hanson, Seth D. Friedman, Thomas C. Register et al. · 2021 · Alzheimer s & Dementia
94. Neuropsychological measures predict decline to Alzheimer's dementia from mild cognitive impairment.
    Mathew James Summers, Nichole L. Saunders · 2012 · Neuropsychology
95. Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer's disease model
    Hyunjung Baek, Minsook Ye, Geun‐Hyung Kang, Chanju Lee, Gihyun Lee, Da Bin Choi, Jaehoon Jung, Hyunseong Kim, Seonhwa Lee, Jin Su Kim et al. · 2016 · Oncotarget
96. Late-onset Alzheimer Disease
    Rabinovici, Gil D. · 2019 · Continuum
97. Low Cardiac Index Is Associated With Incident Dementia and Alzheimer Disease: The Framingham Heart Study
    Jefferson, Angela L., Beiser, Alexa S., Himali, Jayandra J., Seshadri, Sudha, O’Donnell, Christopher J., Manning, Warren J., Wolf, Philip A., Au, Rhoda, Benjamin, Emelia J. · 2015 · Circulation
98. Delphi definition of the EADC‐ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance
    Marina Boccardi, Martina Bocchetta, Liana G. Apostolova, Josephine Barnes, George Bartzokis, Gabriele Corbetta, Charles S DeCarli, Leyla deToledo‐Morrell, Michael Firbank, Rossana Ganzola et al. · 2014 · Alzheimer s & Dementia
99. Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer’s disease in the 3xTg-AD mouse model
    Alfonso Grimaldi, Carlo Brighi, Giovanna Peruzzi, Davide Ragozzino, Valentina Bonanni, Cristina Limatola, Giancarlo Ruocco, Silvia Di Angelantonio · 2018 · Cell Death and Disease
100. Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium
     Toji Miyagawa, Danielle E. Brushaber, Jeremy A. Syrjanen, Walter K. Kremers, Julie A. Fields, Leah K. Forsberg, Hilary W. Heuer, David S. Knopman, John Kornak, Adam L. Boxer et al. · 2020 · Alzheimer s & Dementia